Skip to content

Menu

Drug Enforcement Analytics LLC logo
HomeAboutResourcesContact
Search
Close
Drug PolicyDEA ComplianceEnforcement ActionsDEA Final OrdersLegislationDue Diligence
All Topics
Subscribe

DEA Chronicles

Controlled Substance Litigation & Compliance Issues

Diversion Control Program

Subscribe to Diversion Control Program via RSS

DEA Proposes Changes to Theft/Loss Reporting and Finalizes New Registration Fees

By Larry P. Cote on July 28, 2020
Posted in Drug Policy
Theft and Loss Reporting

On July 29, 2020, the Drug Enforcement Administration (DEA) issued a Notice of Proposed Rulemaking (NPRM) related to the reporting of thefts or significant losses of controlled substances.  Specifically, DEA proposes two changes to the reporting process:

DEA Proposes 21% Increase in Registration Fees

By Larry P. Cote on March 12, 2020
Posted in Drug Policy

MoneyOn March 13, 2020, the Drug Enforcement Administration (DEA) issued a Notice of Proposed Rulemaking (NPRM) seeking to raise registration fees on all DEA registrants. The proposed fees represent a 21% increase over current fees for all registrant categories. DEA indicates that the increase will provide an additional $318 million for the Diversion Fee Account over the next three fiscal years.

As discussed here, the Controlled Substances Act requires  that registration fees “shall be set at a level that ensures the recovery of the full costs of operating the various aspects of [the diversion control program].” 21 USC 886a(1)(C). DEA alleges in the NPRM that “[w]ithout an increase in registration fees, DEA will be unable to continue current operations” and will be unable to comply with the statutory mandate to recover all costs associated with managing the Diversion Control Program (DCP).

To support this doom and gloom prediction, DEA points to several reasons to justify the fee increase. They include, but are not limited to, the ongoing opioid crisis, the growing number of DEA registrants, a need for additional personnel at Headquarters and in Field Division Offices throughout the country, and additional requirements imposed by Congress in recent legislation.

Drug Enforcement Analytics LLC logo
Published by
Larry P. Cote of Drug Enforcement Analytics LLC
RSS LinkedIn Twitter
DisclaimerPrivacy Policy

About Our Firm

Our company is a veteran-owned business that offers compliance solutions, expertly delivered, to assist our industry partners with meeting their controlled substance compliance obligations.

Topics

Archives

Copyright © 2025, Drug Enforcement Analytics LLC. All Rights Reserved. Attorney Advertising.
Law blog design & platform by LexBlog LexBlog Logo